State Street SPDR S&P Biotech ETF
XBI
AMEX
Financial Services
Asset Management
€ 129,44
▼
€ 2,38
(-1,81%)
Company Details
In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI").
Dagbereik
—
52-Weeksbereik
—
Volume
—
Openen —
50D / 200D Gem.
—
50D / 200D Gem.
—
Performance
Moderate (34,3%)
↘ Decelerating
1W
▲ 2,54%
1M
▲ 3,70%
3M
▲ 8,48%
6M
▲ 32,62%
YTD
▲ 8,11%
1Y
▲ 80,60%
3Y
▲ 71,06%
1M return (+3.7%) is stronger than 1W (+2.54%) — gains are slowing
Koershistorie
Koersdoel Analisten
Geen analistendekking beschikbaar
Winstschattingen
Geen toekomstige schattingen beschikbaar
No quarterly estimates available
No fundamental snapshot available yet.
{"event":"ticker_viewed","properties":{"ticker":"XBI","listing_kind":"stock","pathname":"/stocks/xbi","exchange":"AMEX","country":"US"}}